{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:59:57Z","timestamp":1792839597297,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.4065\/mcp.2009.0534","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T02:08:26Z","timestamp":1270087706000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"title":["Pain Management in the Cirrhotic Patient: The Clinical Challenge"],"prefix":"10.4065","volume":"85","author":[{"given":"Natasha","family":"Chandok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly D.S.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.4065\/mcp.2009.0534_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.4065\/mcp.2009.0534_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1389200043489054","article-title":"The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes","volume":"5","author":"Elbekai","year":"2004","journal-title":"Curr Drug Metab"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-199937010-00002","article-title":"Pharmacokinetics of opioids in liver disease","volume":"37","author":"Tegeder","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.4065\/mcp.2009.0534_bib5","first-page":"898","article-title":"Pharmacokinetics and metabolism of acetaminophen in normal, alcoholic and cirrhotic subjects","volume":"7","author":"Villeneuve","year":"1983","journal-title":"Gastroenterol Clin Biol"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2002-30099","article-title":"Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions","volume":"22","author":"Bohan","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00002018-200528060-00005","article-title":"Dose adjustment in patients with liver disease","volume":"28","author":"Delco","year":"2005","journal-title":"Drug Saf"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00002018-200831030-00007","article-title":"Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendations","volume":"31","author":"Rossi","year":"2008","journal-title":"Drug Saf"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2008-1073114","article-title":"Etiologies of acute liver failure","volume":"28","author":"Lee","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pds.1191","article-title":"Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States","volume":"15","author":"Nourjah","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.4065\/mcp.2009.0534_bib13","author":"US Department of Health and Human Services"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.mjt.0000140216.40700.95","article-title":"The therapeutic use of acetaminophen in patients with liver disease","volume":"12","author":"Benson","year":"2005","journal-title":"Am J Ther"},{"issue":"9","key":"10.4065\/mcp.2009.0534_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1592\/phco.27.9.1219","article-title":"Does therapeutic use of acetaminophen cause acute liver failure?","volume":"27","author":"Dart","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15563650601120792","article-title":"Aminotransferase activities in healthy subjects receiving three-day dosing of 4, 6, or 8 grams per day of acetaminophen","volume":"45","author":"Temple","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2165\/00003495-198325030-00002","article-title":"Paracetamol overdosage: pharmacological considerations and clinical management","volume":"25","author":"Prescott","year":"1983","journal-title":"Drugs"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/0016-5085(95)90758-0","article-title":"A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)","volume":"109","author":"Makin","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib19","first-page":"21","article-title":"Hepatic and renal toxicity of paracetamol in chronic alcoholic patient","volume":"17","author":"Pezzano","year":"1988","journal-title":"Presse Med"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib20","first-page":"507","article-title":"Hepatotoxicity caused by therapeutic doses of paracetamol in alcoholics: report of 2 cases of fatal hepatitis in cirrhosis","volume":"150","author":"Mofredj","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1345\/aph.1A035","article-title":"Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors","volume":"36","author":"Bolesta","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.4065\/mcp.2009.0534_bib22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1478-3231.2008.01816.x","article-title":"Preventative hepatology: minimising symptoms and optimising care","volume":"28","author":"Hirschfield","year":"2008","journal-title":"Liver Int"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.1983.14","article-title":"Acetaminophen in chronic liver disease","volume":"33","author":"Benson","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1389200043335531","article-title":"Cytochrome P450 and liver diseases","volume":"5","author":"Villeneuve","year":"2004","journal-title":"Curr Drug Metab"},{"issue":"23","key":"10.4065\/mcp.2009.0534_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/mcp.2009.0534_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2125.2000.00167.x","article-title":"Paracetamol, alcohol and the liver","volume":"49","author":"Prescott","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.4065\/mcp.2009.0534_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-5-13","article-title":"The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients: a multicenter randomized study","volume":"5","author":"Kuffner","year":"2007","journal-title":"BMC Med"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2036.2007.03368.x","article-title":"A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol","volume":"26","author":"Heard","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00542162","article-title":"Naproxen disposition in patients with alcoholic cirrhosis","volume":"27","author":"Williams","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib30","first-page":"530","article-title":"Arachidonic acid derivatives and renal function in liver cirrhosis","volume":"17","author":"Laffi","year":"1997","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib31","first-page":"11","article-title":"Influence of nonsteroidal antiinflammatory drugs in gastrointestinal bleeding due to gastroduodenal ulcers or erosions in patients with liver cirrhosis","volume":"29","author":"Castro-Fernandez","year":"2006","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1345\/aph.1G493","article-title":"Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs","volume":"40","author":"Hur","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.4065\/mcp.2009.0534_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12110","article-title":"Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation","volume":"12","author":"Chen","year":"2008","journal-title":"Health Technol Assess"},{"issue":"suppl 1","key":"10.4065\/mcp.2009.0534_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-8278(02)80720-6","article-title":"Effect of celecoxib on renal function in cirrhotic patients with ascites: a pilot study [abstract]","volume":"36","author":"Guevara","year":"2002","journal-title":"J Hepatol"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1990.tb03638.x","article-title":"The metabolism and bioavailability of morphine in patients with severe liver cirrhosis","volume":"29","author":"Hasselstrom","year":"1990","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.4065\/mcp.2009.0534_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.4065\/mcp.2009.0534_bib37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/54.12.1267","article-title":"Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis","volume":"54","author":"Haberer","year":"1982","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/clpt.1981.172","article-title":"Methadone disposition in patients with chronic liver disease","volume":"30","author":"Novick","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003246-200201000-00020","article-title":"Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult","volume":"30","author":"Jacobi","year":"2002","journal-title":"Crit Care Med"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib40","first-page":"99","article-title":"Pharmacokinetics of oral tramadol in patients with liver cancer","volume":"4","author":"Kotb","year":"2008","journal-title":"J Opioid Manag"},{"issue":"6","key":"10.4065\/mcp.2009.0534_bib41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aem325","article-title":"Serotonin syndrome triggered by tramadol","volume":"99","author":"Vizcaychipi","year":"2007","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.4065\/mcp.2009.0534_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/lt.20688","article-title":"Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease","volume":"12","author":"DiMartini","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.4065\/mcp.2009.0534_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: an interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib44","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.4065\/mcp.2009.0534_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00139709-200524030-00013","article-title":"Tricyclic antidepressant poisoning: cardiovascular toxicity","volume":"24","author":"Thanacoody","year":"2005","journal-title":"Toxicol Rev"},{"issue":"1","key":"10.4065\/mcp.2009.0534_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15360280801989450","article-title":"Update on treatments for neuropathic pain","volume":"22","author":"Harvey","year":"2008","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"10","key":"10.4065\/mcp.2009.0534_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/MEG.0b013e328300c978","article-title":"Pregabalin as a probable cause of acute liver injury","volume":"20","author":"Einarsdottir","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611603327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611603327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:25:53Z","timestamp":1675866353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611603327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0025619611603327"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2009.0534","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain Management in the Cirrhotic Patient: The Clinical Challenge","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2009.0534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}